Results 201 to 210 of about 345,366 (342)

Precision therapies for genetic epilepsies in 2025: Promises and pitfalls

open access: yesEpilepsia Open, EarlyView.
Abstract By targeting the underlying etiology, precision therapies offer an exciting paradigm shift to improve the stagnant outcomes of drug‐resistant epilepsies, including developmental and epileptic encephalopathies. Unlike conventional antiseizure medications (ASMs) which only treat the symptoms (seizures) but have no effect on the underlying ...
Shuyu Wang   +3 more
wiley   +1 more source

Asiatic Acid Alleviates Renal Damage by Upregulating STBD1-Mediated Glycophagy in Diabetic Kidney Disease. [PDF]

open access: yesBiomedicines
Guo L   +16 more
europepmc   +1 more source

Advancements in Identification of Low‐Molecular‐Weight Peptides in Food Protein Hydrolysates

open access: yesFood Frontiers, EarlyView.
During the sample processing stage, sample collection, extraction and purification are carried out first to ensure the accuracy of the experimental data. Then, multi‐dimensional techniques such as mass spectrometry and chromatography are employed for in‐depth analysis of the samples.
Zhihui Chang   +4 more
wiley   +1 more source

Exploring the Potential of Tsuruazuki Bean as a Functional Food to Curb Obesity Using Human Amniotic Epithelial Cells and 3T3‐L1 Preadipocytes

open access: yesFood Frontiers, EarlyView.
Obesity is a global health problem that requires research and regulatory attention. This research aims to investigate transcriptome‐wide changes induced by Vigna umbellata (Tsuruazuki) using a stem cell‐based tool and preadipocytes to explore its untapped potential as a functional food for anti‐obesity applications.
Elda Nurafnie Ibnu Rasid   +6 more
wiley   +1 more source

Bioactive polysaccharides and their potential health benefits in reducing the risks of metabolic syndrome: A review

open access: yesFood Biomacromolecules, EarlyView.
Abstract Metabolic syndrome (MetS) is a complex noncommunicable condition characterized by central obesity, insulin resistance, hyperlipidemia, hypertension, and hyperglycemia. Epidemiological evidence shows that MetS affects a third of the global population; however, due to its complex pathogenesis and limited drug therapy options, the increasing ...
Josiah Owuor Oyalo   +3 more
wiley   +1 more source

Mauriac syndrome: a rare complication in patients with type 1 diabetes mellitus. [PDF]

open access: yesEndocrinol Diabetes Metab Case Rep
Torres JO   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy